Cambrian Biopharma is the largest investor in cancer immunotherapy developer Sensei Biotherapeutics, which has filed to raise up to $100m.

The drama content producer, which counts iQiyi among its investors, has gone public in Hong Kong and seen its share price rise 84% on its first day of trading.

The stem cell therapy developer has filed to go public seven months after closing $700m in funding from investors including Alphabet unit GV.

Three years after launching to commercialise stem cell research from Harvard University, Sana has filed for an initial public offering.

Mutschler Group and SoftBank Vision Fund are in line for exits as the online car dealership reveals plans to list its shares in Frankfurt.

The behavioural health assistance platform will get a public listing through the deal, which follows $110m from investors including SoftBank.

The JF Shea-backed social commerce marketplace priced its shares above the range in an offering valuing it at about $3bn.

Mitsui, Edison Energy, BMW, Daimler, General Motors and Exelon-backed electric bus manufacturer Proterra achieved a $1.6bn enterprise value in the deal.

Microsoft, PayU and Boston Consulting Group are among the investors in digital currency platform developer Bakkt, which will list in a reverse merger set to value it at $2.1bn.

SoftBank and Renren-backed online financial services provider SoFi will list on the New York Stock Exchange at an $8.65bn valuation double that of its last round.